Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic Stroke

NCT07423975 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

159

Enrollment

OTHER

Sponsor class

Conditions

Stroke Acute
Endovascular Treatment

Interventions

DRUG: High-dose Anakinra
DRUG: Low-dose Anakinra
OTHER: Standard medical treatment

Sponsor

Beijing Tiantan Hospital